Build the company your science deserves.
BioBuild is an eight-week commercialization cohort helping early-stage
bioscience companies turn promising technologies into focused,
fundable, and actionable strategies.
Expert-led commercialization guidance
Dedicated company mentorship
Practical tools and milestone planning
Applications close November 20, 2026, or when 10 qualifying
companies have been selected, whichever comes first.
Great science does not commercialize itself.
progress. Founders must make interconnected decisions about customers,
development, regulation, intellectual property, reimbursement, partnerships,
operations, and funding. BioBuild brings those decisions
into one structured experience, helping companies reduce uncertainty,
prioritize the right milestones, and build a stronger path forward.
Built for companies ready to move beyond the idea stage.
BioBuild is designed for early-stage bioscience teams with a defined
innovation and a meaningful milestone ahead.
Defined Innovation
A therapeutic, diagnostic, medical device, digital health solution,
research tool, or other bioscience technology with a clear intended use.
Early Evidence
Preliminary data, proof of concept, validation work, or an early
prototype that supports continued development.
A Near-Term Goal
A company preparing for funding, customer validation, regulatory
planning, clinical development, a pilot, or a strategic partnership.
A clearer strategy for what comes next.
BioBuild is designed to produce decisions, tools, and momentum that
continue serving your company after the cohort ends.
Commercial Focus
Clarify the customer, market opportunity, competitive position, and
commercialization pathway.
Development Priorities
Connect technical progress with clinical, preclinical, and regulatory
priorities.
Business Strategy
Strengthen the company’s thinking around partnerships, reimbursement,
operations, and business model development.
Funding Readiness
Develop a clearer milestone story and communicate why the company is
ready for its next stage of support.
From promising science to a commercialization strategy.
BioBuild helps founders answer the critical questions that determine
whether a breakthrough becomes a successful company.
You’ll leave with:
- A commercialization roadmap
- A validated customer strategy
- A development and regulatory plan
- A stronger competitive position
- A clear path to funding and partnerships
- An investor-ready story
Framing the Opportunity & Commercialization Pathway
Define your opportunity, clarify your commercialization strategy,
and establish the roadmap that will guide your company throughout
the program.
Customer Discovery & Market Validation
Identify your ideal customers, validate market need, and refine your
value proposition through customer insights.
Clinical and Pre-Clinical Development Strategy
Develop a strategic plan for generating the scientific evidence
needed to advance your technology toward commercialization.
Regulatory Pathways
Understand regulatory pathways, key milestones, and how early
planning can reduce risk and strengthen development strategy.
IP Strategy & Competitive Positioning
Strengthen your competitive advantage by protecting your innovation
and understanding where your technology fits in the market.
Reimbursement Pathways & Partnership Development
Explore reimbursement strategy, market access, and partnerships
that support successful commercialization.
Team, Operations & Business Model Strategy
Build a stronger company by refining your team, business model,
operational strategy, and growth milestones.
Investor Narrative & Milestone Pitch
Bring it all together into a compelling company narrative that
clearly communicates your vision, progress, and next milestones to
investors and partners.
Learn. Apply. Build.
Learn from Experts
Participate in focused sessions led by experienced professionals
across the bioscience commercialization pathway.
Apply It to Your Company
Translate each session into company-specific decisions, tools, and
next steps.
Build with Support
Work with a dedicated mentor and a cohort of other bioscience founders
navigating similar decisions.
The experts bring the knowledge. Your mentor helps you use it.
Each participating company will be paired with an experienced mentor
for the duration of the cohort.
Through weekly meetings, mentors will help founders think through
challenges, identify blind spots, connect lessons across the program,
and maintain momentum toward their most important milestone.
Mentors serve as trusted strategic sounding boards. They are not expected
to solve every problem or act as unpaid consultants.
More support. A stronger path forward.
BioBuild companies receive far more than an eight-week program. Each
participating company also receives services, relationships, and
resources designed to help maintain momentum beyond the cohort.
$62,500
$6,250
$750
per participating company
The remaining program value is supported through BioBuild funding and contributed resources.
BioMembership
One year of BioMembership keeps companies connected to OBI resources,
meeting space, events, EIR appointments, Startup In A Box, and the
broader OBI community.
$7,500
$750
BioBuild Course
Eight weeks of interactive, expert-led commercialization education
with practical tools and frameworks participants can apply directly
to their companies.
$35,000
$3,500
Dedicated Mentoring
Each company receives an experienced mentor who provides strategic
guidance, connections, and real-world perspective throughout the
eight-week program.
$15,000
$1,500
BioBuild Forum & Graduation Celebration
An in-person event to celebrate company progress and connect
participants with investors, ecosystem partners, mentors, and the
broader Oregon bioscience community.
$5,000
$500
And the support doesn’t stop there.
BioBuild companies also gain access to additional resources and
relationships designed to help them continue moving forward after
the program.
Ecosystem Partner Resources
Professional services, memberships, credits, resources, introductions,
and other opportunities contributed by BioBuild Ecosystem Partners.
Private Program Resources
Access to session recordings, materials, tools, and other resources
participants can revisit throughout the program.
OBI Ecosystem Connections
Relationships with mentors, subject matter experts, investors,
partners, and trusted resources across Oregon’s bioscience ecosystem.
Continued OBI Community
A full year of BioMembership keeps companies connected to OBI
resources, events, and the broader community after BioBuild concludes.
Share your progress with Oregon’s bioscience community.
The cohort culminates in the BioBuild Forum & Graduation Celebration
at the Oregon Bioscience Incubator.
Participating companies will share their progress, connect with investors
and ecosystem partners, and celebrate the milestones achieved during the
program.
March 18, 2027
Built for Oregon’s bioscience community.
bioscience-focused incubator and a statewide resource supporting startups
across therapeutics, diagnostics, medical devices, digital health, and
other life science sectors. OBI connects bioscience innovators with the
space, expertise, programs, mentors, and relationships needed to move
promising science forward.
Questions? We’ve got answers.
Everything you need to know before applying to BioBuild.
What is BioBuild?
Bioscience Incubator designed for early-stage, Oregon-based bioscience
companies.Through expert-led sessions, dedicated mentorship, and hands-on
commercialization planning, participating companies will strengthen
the strategies needed to move promising technologies toward market
and build a clearer path forward.
Who is BioBuild for?
moved beyond the idea stage and are ready to actively work on
commercialization.Companies should have a defined technology or product, early evidence
or proof of concept, and a team prepared to engage in areas such as
market validation, development strategy, regulatory planning,
intellectual property, reimbursement, partnerships, business strategy,
and investor readiness.
BioBuild is generally best suited for technologies around
TRL 3–6, although technology readiness will be
considered alongside commercial readiness and overall program fit.
Does my company need to be based in Oregon?
and your company must be registered to do business in Oregon before
submitting an application.If your company is not yet registered, please complete your registration
with the Oregon Secretary of State before applying.
What types of companies can apply?
including companies developing therapeutics, diagnostics, medical
devices, digital health technologies, research and life science tools,
biomanufacturing technologies, and other bioscience innovations.
When does BioBuild take place?
every Tuesday through March 2, 2027.Weekly sessions are held virtually from
10:00–11:30 AM PT.
The program concludes with the in-person
BioBuild Forum & Graduation Celebration on Thursday,
March 18, 2027, at the Oregon Bioscience Incubator in Portland.
What is the time commitment?
weekly virtual sessions, meet weekly with their assigned BioBuild
mentor, and complete company-specific work between sessions.
Companies are also expected to participate in the BioBuild Forum
& Graduation Celebration on March 18, 2027.
What will we work on during the eight weeks?
- Framing the Opportunity & Commercialization Pathway
- Customer Discovery & Market Validation
- Clinical and Pre-Clinical Development Strategy
- Regulatory Pathways
- IP Strategy & Competitive Positioning
- Reimbursement Pathways & Partnership Development
- Team, Operations & Business Model Strategy
- Investor Narrative & Milestone Pitch
The emphasis is on applying these topics directly to your company so
you leave BioBuild with clearer strategies, defined milestones, and
a more actionable commercialization roadmap.
How does mentorship work?
duration of the program.Companies will meet with their mentor weekly to discuss progress,
work through challenges, pressure-test assumptions, and apply the
program to their specific company. Mentors serve as experienced
strategic sounding boards and guides rather than consultants doing
the work for the company.
How many companies will participate?
10 Oregon bioscience companies.The cohort is intentionally small so participating companies can
receive meaningful expert guidance, dedicated mentorship, and
individualized support.
When do applications open and close?
been selected or on November 20, 2026, whichever occurs first.
Because the cohort may fill before November 20, interested companies
are encouraged to apply early.
How much does BioBuild cost?
is not accepted, the $750 program fee will be refunded
in full.
If your company is accepted into BioBuild, the program fee is
non-refundable.
Does applying guarantee a place in the cohort?
technology and commercial readiness, near-term commercialization needs
and milestones, team commitment, and the company’s ability to benefit
from the BioBuild experience.
Submitting an application and payment does not guarantee acceptance.
Companies that are not accepted will receive a full refund of the
$750 program fee.
What happens at the end of BioBuild?
BioBuild Forum & Graduation Celebration on Thursday,
March 18, 2027, at the Oregon Bioscience Incubator in Portland.The Forum will bring together BioBuild companies, mentors, subject
matter experts, investors, ecosystem partners, and members of
Oregon’s bioscience community to celebrate progress, build
connections, and recognize the cohort.
We’d be happy to help determine whether BioBuild is a good fit for your
company. Contact us at
info@otradi.org.
Ready to build what comes next?
BioBuild is selecting 10 Oregon bioscience companies for its 2027 cohort.
Applications close November 20, 2026, or when 10 qualifying companies
have been selected, whichever comes first.
$750 per company. Companies not selected for the cohort
will receive a full refund.